← SynDRA
dexamethasone palmitate
SynDRA canonical compound SYN0041659 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | glucocorticoid receptor agonist |
|---|
| Indication | rheumatoid arthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
- NR3C1
- AR
- Ar
- Fabp1
- NR3C2
- Nr3c1
- PGR
- ANXA1
- CYP3A4
- CYP3A5
- NOS2
- NR0B1
Mechanisms of action (all sources)
- NR3C1 AGONIST
- ESRRA AGONIST
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Inflammatory Agents
- Antiemetics
- Antineoplastic Agents
- Antineoplastic Agents, Hormonal
- Central Nervous System Agents
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Peripheral Nervous System Agents
- Anti-Allergic Agents
ATC classes
- A01A · STOMATOLOGICAL PREPARATIONS
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- S02B · CORTICOSTEROIDS
- D07A · CORTICOSTEROIDS, PLAIN
- D10A · ANTI-ACNE PREPARATIONS FOR TOPICAL USE
- S01C · ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
- C05A · AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
- D07X · CORTICOSTEROIDS, OTHER COMBINATIONS
- H02A · CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
- S01B · ANTIINFLAMMATORY AGENTS
- CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
- CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Cross-references
Synonyms
- limethason
- limethasone
- Dexamethasone 21-palmitate
- NOVA63035
- RefChem:132373
- DTXCID202903
- Limethason
- Dexamethasone palmitate [JAN]
- C38H59FO6
- Dexamethasone palmitate (JAN)
- BRN 6031847
- MFCD01698988
- UNII-601XWN7060
- Limethason (TN)
- NOVA-63035
- SCHEMBL93887
- orb1308392
- orb3025698
- CHEBI:31471
- MSK159619
- s5184
- AKOS040741625
- FD21400
- MSK159619-100A
- DEXAMETHASONE PALMITATE [WHO-DD]
- NCGC00522021-01
- DA-62804
- MS-30856
- SY357842
- HY-128922
- CS-0102469
- D01615
- G13029
- T15102
- F979218
- Dexamethasone palmitate Solution in Acetonitrile, 100ug/mL
- Dexamethason-21-palmitat
- Dexamethasonpalmitat
Reported adverse events
- Exophthalmos
- Bradycardia
- Acne
- Anaphylactoid reaction
- Hypertension
- Sodium retention
- Fluid retention
- Petechiae
- Fungal infection
- Peptic ulcer
- Erythema
- Increased appetite
Look up dexamethasone palmitate in the interactive SynDRA portal →